Browse
Submit Data
Databases
API
Help

Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcription profiling of human lymphoblastoid cells from control males without autism

ABSTRACT: gene expression profiles of lymphoblastoid cells from individuals with autism and full mutation of FMR1 Experiment Overall Design: Cy5; each individual with autism and FMR1FM Experiment Overall Design: Cy3; pool of 14 unrelated individuals.

ORGANISM(S): Homo sapiens

SUBMITTER: Yuhei Nishimura

PROVIDER: E-GEOD-7316 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Publications

Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways.

Nishimura Yuhei Y Martin Christa L CL Vazquez-Lopez Araceli A Spence Sarah J SJ Alvarez-Retuerto Ana Isabel AI Sigman Marian M Steindler Corinna C Pellegrini Sandra S Schanen N Carolyn NC Warren Stephen T ST Geschwind Daniel H DH

Human molecular genetics 20070521 14

Autism is a heterogeneous condition that is likely to result from the combined effects of multiple genetic factors interacting with environmental factors. Given its complexity, the study of autism associated with Mendelian single gene disorders or known chromosomal etiologies provides an important perspective. We used microarray analysis to compare the mRNA expression profile in lymphoblastoid cells from males with autism due to a fragile X mutation (FMR1-FM), or a 15q11-q13 duplication (dup(15q ...[more]

PMID: 17519220

Similar Datasets

Transcription profiling of human lymphoblastoid cells (GEO Super Series)

Project description:This SuperSeries is composed of the following subset Series:; GSE7315: autism with dup(15q); GSE7316: autism with FMR1FM; GSE7317: control males Experiment Overall Design: Refer to individual Series

2008-06-15 | E-GEOD-7329 | biostudies-arrayexpress

Transcription profiling of human lymphoblastoid cells from control males without autism

Project description:gene expression profiles of lymphoblastoid cells from control males without autism Experiment Overall Design: Cy5; each control male Experiment Overall Design: Cy3; pool of 14 unrelated individuals.

2008-06-15 | E-GEOD-7317 | biostudies-arrayexpress

Transcription profiling of human lymphoblastoid cells from individuals with autism and duplication of 15q11-13autism with dup(15q)

Project description:gene expression profiles of lymphoblastoid cells from individuals with autism and duplication of 15q11-13 Experiment Overall Design: Cy5; each male with autism and dup(15q) Experiment Overall Design: Cy3; pool of 14 unrelated individuals.

2008-06-15 | E-GEOD-7315 | biostudies-arrayexpress

Analysis of the Byssus of Chinese Green Mussel proteomics by LC-MS/MS

Project description:Here, we integrated high-throughput transcriptome and proteome sequencing to construct a comprehensive protein database for the byssus of Chinese green mussel (Perna viridis), aiming at providing novel insights into the molecular mechanisms of byssal binding to heavy metals.

2019-04-30 | PXD009183 | Pride

Chromosomal aberration of malignant pleural mesothelioma cell lines

Project description:To identify regions that display DNA copy number alterations in malignant pleural mesothelioma (MPM), we carried out array comparative genomic hybridization (CGH) analysis with 14 MPM cell lines. Regions of genomic aberrations observed in >20% of individuals were 9p21.3, 13q12.11, 16p13, and 22q12.2 of losses. The most frequent alteration was 9p21.3, which include the p16INK4/p14ARF. The loss of 22q12.2 regions include the NF2 was observed in 3 out of 14 cell lines. In 3 cell lines, loss of 13q12.11 region which contains Large Tumor Suppressor, homolog 2 (LATS2) was detected. Human malignant pleural mesothelioma cell lines were profiled on Agilent 244K aCGH arrays according to manufacturer’s instructions. Pooled normal human genomic DNA was used as the reference.

2010-06-15 | E-GEOD-22237 | biostudies-arrayexpress

Hepatic proteome analysis of Atlantic salmon (Salmo salar) after exposure to environmental concentrations of human pharmaceuticals

Project description:Pharmaceuticals are pseudo persistent aquatic pollutants with unknown effects at environmentally relevant concentrations. Atlantic salmon (Salmo salar) were exposed to Acetaminophen: 54.77 ± 34.67; Atenolol: 11.08 ± 7.98 and Carbamazepine: 7.85 ± 0.13 µg•L-1 for 5 days. After Acetaminophen treatment, 19 proteins were differently expressed, of which 11 were significant with respect to the control group (eight up-regulated and three down-regulated). After Atenolol treatment, 7 differently expressed proteins were obtained in comparison with the control, of which 6 could be identified (four up-regulated and 2 down-regulated). Carbamazepine exposure resulted in 15 differently expressed proteins compared with the control, with 10 of them identified (seven up-regulated and three down-regulated). Out of these, 3 features were common between Acetaminophen and Carbamazepine and one between Carbamazepine and Atenolol. One feature was common across all treatments. Principal component analysis and heat map clustering showed a clear grouping of the variability due to the applied treatments. The obtained data suggest (1) that exposure to environmentally relevant concentrations of the pharmaceuticals alters the hepatic protein expression profile of the Atlantic salmon; and (2) the existence of treatment specific processes that may be useful for biomarker development.

2014-11-18 | PXD001354 | Pride

How do consumers deal with stoichiometric constraints?

Project description:Determine gene expression in daphnia exposed to biotic and abiotic stressors. Identify in Daphnia pulex unique gene regulatory patterns involved in the regulation of limited phosphorous. One-condition experiment: Exposed Daphnia pulex for 5 days to phosphorous-limited algae. Biological replicates: 4 exposures, 4 nonexposed controls, grown and harvested in groups of 20 daphnia. One replicate per array.

2012-03-13 | E-GEOD-27959 | biostudies-arrayexpress

A comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants (NimbleGen 2.1M)

Project description:Systematic evaluation of eleven array platforms commonly used for CNV detection to address parameters of quality and CNV calling. 33 Samples

2011-06-30 | E-GEOD-30312 | biostudies-arrayexpress

A comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants (NimbleGen 720K)

Project description:Systematic evaluation of eleven array platforms commonly used for CNV detection to address parameters of quality and CNV calling. 18 Samples

2011-06-30 | E-GEOD-30307 | biostudies-arrayexpress

Recurrent 17q23.2 microdeletion flanked by segmental duplications associated with heart defects and limb abnormalities

Project description:[original title] Identification of recurrent microdeletion on 17q23.2 flanked by segmental duplications associated with heart defects and limb abnormalities. Segmental duplications, are known to mediate non-allelic homologous recombination and have been suggested to be hotspots in chromosome evolution and human genomic instability. We report the identification by microarray-based comparative genomic hybridization (aCGH) of seven individuals with microdeletions of 17q23.1q23.2. The clinical information obtained from six individuals for whom medical records were available showed common features including mild to moderate developmental delay, postnatal growth retardation, eye anomalies, heart defects and hand/foot/limb abnormalities. The presence in the deletion region of TBX2 and TBX4, transcription factors belonging to a family of genes implicated in a variety of developmental pathways including those of heart and limb, suggests that these genes may play an important role in the phenotype of this emerging syndrome. aCGH control vs. patient, total of 7 patients Lowest normalized log2 ratio = patient 1: -1.99; patient 2: -1.87; patient 3: -2.16; patient 4: -2.11; patient 5: -1.974802452; patient 6: -2.23; patient 7: -1.36.

2010-12-31 | E-GEOD-19932 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data